Comparing chlorhexidine and alcohol hand rubs to reduce infections in the NICU

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Neonates under 37 weeks gestation admitted to the Alexandria University Children's Hospital NICU will be assigned to care where staff use either alcohol-based hand rub or chlorhexidine gluconate for hand hygiene. The trial compares rates of healthcare-associated infections between the two hand-rub approaches. Infants with major congenital abnormalities, immunodeficiency, inborn errors of metabolism, early-onset sepsis, or who are older than 72 hours at enrollment are excluded, and parental consent is required. Primary outcomes focus on incidence of neonatal sepsis and other HCAIs during the NICU stay.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Neonates \<37 weeks gestational age admitted to NICU of Alexandria University Children's Hospitals

Exclusion Criteria:

* Patients with any of the following will be excluded:

  1. Obvious major congenital abnormalities, immunodeficiency and inborn error of metabolism.
  2. Early onset sepsis (before the third day).
  3. Infants more than 72 hours of age at the time of randomization.
  4. Parental consent lacking/refusal.

Where it's running

• Marwa Mohamed Farag
  Alexandria, Egypt Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Selective antibiotics when symptoms develop versus universal antibiotics for preterm neonates

  In preterm babies at risk for sepsis, researchers test whether giving antibiotics only to those who show symptoms is as safe as giving antibiotics to all at-risk babies in the first week of life.

  Recruiting at 9 sites Phase 3 Indian Council of Medical Research · Chandigarh, Chandigarh and 8 other locations · NCT06377397

• Using presepsin to reduce unnecessary antibiotics in preterm infants

  This study is testing if using a blood marker called presepsin can help reduce unnecessary antibiotic use in preterm infants at risk for infection.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT06100614

• Understanding how piperacillin/tazobactam works in pregnant women and their newborns

  This study looks at how the antibiotic piperacillin/tazobactam works in pregnant women and their newborns to see if it can safely help prevent serious infections in babies at risk.

  Recruiting Shandong University · Jinan · NCT06076200

• Amniotic fluid and the extremely preterm baby's gut

  We will see if amniotic fluid from extremely preterm births (24+0 to 27+6 weeks) shows changes that relate to gut problems such as necrotizing enterocolitis or sepsis in very preterm infants.

  Recruiting at 2 sites Maxima Medical Center · Amsterdam and 1 other locations · NCT07152106

• POP-Score: A simple, non-invasive test to see if newborns might have early infection

  This study tests whether the POP-Score, a non-invasive measure using NIRS and routine vitals, can predict elevated CRP in term and near-term neonates within 48 hours of birth.

  Recruiting Medical University of Graz · Graz, Styria · NCT07109856

• MDW as a new marker for late-onset sepsis in preterm newborns

  Researchers are testing whether monocyte distribution width (MDW) can help detect late-onset neonatal sepsis in preterm babies.

  Recruiting Tanta University · Tanta · NCT07821190

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.